Published in BMC Infect Dis on November 27, 2009
Ovine serum biomarkers of early and late phase scrapie. BMC Vet Res (2010) 0.82
Proteomics analysis of amyloid and nonamyloid prion disease phenotypes reveals both common and divergent mechanisms of neuropathogenesis. J Proteome Res (2014) 0.77
Serum protein profiles as potential biomarkers for infectious disease status in pigs. BMC Vet Res (2012) 0.75
Investigation of serum protein profiles in scrapie infected sheep by means of SELDI-TOF-MS and multivariate data analysis. BMC Res Notes (2013) 0.75
A novel progressive spongiform encephalopathy in cattle. Vet Rec (1987) 4.39
Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science (1997) 3.68
Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A (1983) 2.76
A systems approach to prion disease. Mol Syst Biol (2009) 2.49
Scrapie strain variation and mutation. Br Med Bull (1993) 2.06
Chronic wasting disease in deer and elk in North America. Rev Sci Tech (2002) 2.00
High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem (2007) 1.93
Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci U S A (1997) 1.79
Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang (2006) 1.76
Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci U S A (2003) 1.75
Atypical scrapie cases in Germany and France are identified by discrepant reaction patterns in BSE rapid tests. J Virol Methods (2004) 1.68
Gene expression profiling of the preclinical scrapie-infected hippocampus. Biochem Biophys Res Commun (2005) 1.21
Tests for BSE evaluated. Bovine spongiform encephalopathy. Nature (1999) 1.15
The transmissible spongiform encephalopathies: emerging and declining epidemics. Biochem Soc Trans (2006) 1.06
Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies. Haemophilia (2006) 0.98
Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. J Comp Pathol (2001) 0.96
Early loss of dendritic spines in murine scrapie revealed by confocal analysis. Neuroreport (2001) 0.91
Florid plaques and new variant Creutzfeldt-Jakob disease. Lancet (1997) 0.89
Early unsuspected neuron and axon terminal loss in scrapie-infected mice revealed by morphometry and immunocytochemistry. Neuropathol Appl Neurobiol (1995) 0.88
A comparative proteinomic analysis of nipple aspiration fluid from healthy women and women with breast cancer. Eur J Cancer (2007) 0.87
The use of non-prion biomarkers for the diagnosis of Transmissible Spongiform Encephalopathies in the live animal. Vet Res (2005) 0.86
Unsuspected early neuronal loss in scrapie-infected mice revealed by morphometric analysis. Ann N Y Acad Sci (1994) 0.79
Microdissection: a method developed to investigate mechanisms involved in transmissible spongiform encephalopathy pathogenesis. BMC Infect Dis (2004) 0.79
In vivo detection of metabolic changes in a mouse model of scrapie using nuclear magnetic resonance spectroscopy. J Gen Virol (1991) 0.78
The molecular pathology of scrapie and the biological basis of lesion targeting. Prog Clin Biol Res (1989) 0.78
The genome of a songbird. Nature (2010) 5.90
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet (2004) 4.59
Comparative genome analysis of Salmonella Enteritidis PT4 and Salmonella Gallinarum 287/91 provides insights into evolutionary and host adaptation pathways. Genome Res (2008) 3.54
Methods for interpreting lists of affected genes obtained in a DNA microarray experiment. BMC Proc (2009) 2.80
Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ (2013) 2.74
Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol (2004) 2.47
Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol (2004) 2.44
Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain (2003) 2.42
Planning the human variome project: the Spain report. Hum Mutat (2009) 2.22
Mutations of the prion protein gene phenotypic spectrum. J Neurol (2002) 2.20
Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol (2012) 2.18
Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol (2010) 2.09
Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol (2003) 2.05
Recommendations of the 2006 Human Variome Project meeting. Nat Genet (2007) 1.90
Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol (2006) 1.80
Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ (2009) 1.75
Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer (2008) 1.71
Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children. Genet Med (2010) 1.69
Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World J Gastroenterol (2006) 1.60
Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior. Brain Pathol (2007) 1.59
Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol (2004) 1.56
Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine. Vaccine (2007) 1.53
Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol (2004) 1.52
Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int (2008) 1.51
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathol (2008) 1.51
MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs. J Virol (2008) 1.47
A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro Oncol (2010) 1.46
Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors. Brain (2011) 1.45
Global democratic consensus on neuropathological disease criteria. Lancet Neurol (2002) 1.44
Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ (2002) 1.44
Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease. Invest Ophthalmol Vis Sci (2003) 1.42
Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion. J Gen Virol (2011) 1.40
Transplantation of ocular tissue from a donor with sporadic Creutzfeldt-Jakob disease. Clin Experiment Ophthalmol (2006) 1.39
Tetracyclines affect prion infectivity. Proc Natl Acad Sci U S A (2002) 1.39
Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med (2006) 1.36
Cortical ependymoma or monomorphous angiocentric glioma? Neuropathology (2007) 1.35
The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes. Clin Infect Dis (2010) 1.30
Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol (2012) 1.29
Thermal conductivity of monolayer molybdenum disulfide obtained from temperature-dependent Raman spectroscopy. ACS Nano (2014) 1.29
Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.27
Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol (2006) 1.26
Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC. PLoS One (2012) 1.25
A genomic analysis of chicken cytokines and chemokines. J Interferon Cytokine Res (2005) 1.22
PRNP contains both intronic and upstream regulatory regions that may influence susceptibility to Creutzfeldt-Jakob Disease. Gene (2002) 1.17
Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.17
Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions. Am J Pathol (2003) 1.16
Urinary aprotinin as a predictor of acute kidney injury after cardiac surgery in children receiving aprotinin therapy. Pediatr Nephrol (2008) 1.14
Beyond PrP res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog (2008) 1.14
Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes. Brain Pathol (2002) 1.12
Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain. Ann Neurol (2009) 1.07
GENETICS. The Human Variome Project. Science (2008) 1.07
Heparin enhances the cell-protein misfolding cyclic amplification efficiency of variant Creutzfeldt-Jakob disease. Neurosci Lett (2011) 1.05
IMAD: flexible annotation of microarray sequences. BMC Proc (2009) 1.04
Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection. J Biol Chem (2008) 1.04
Genome sequences of Salmonella enterica serovar typhimurium, Choleraesuis, Dublin, and Gallinarum strains of well- defined virulence in food-producing animals. J Bacteriol (2011) 1.04
Relationships between child, family and neighbourhood characteristics and childhood injury: a cohort study. Soc Sci Med (2005) 1.03
Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies. J Neurooncol (2010) 1.03
Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease. Brain Res Bull (2005) 1.03
Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases. J Gen Virol (2003) 1.03
Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease. Transfusion (2008) 1.03
Carrier testing for spinal muscular atrophy. Genet Med (2010) 1.02
A biomarker panel for peripheral arterial disease. Vasc Med (2008) 1.01
Haptoglobin and serum amyloid A in milk and serum during acute and chronic experimentally induced Staphylococcus aureus mastitis. J Dairy Res (2003) 0.99
Variably protease-sensitive prionopathy in a PRNP codon 129 heterozygous UK patient with co-existing tau, α synuclein and Aβ pathology. Acta Neuropathol (2010) 0.99
Song exposure regulates known and novel microRNAs in the zebra finch auditory forebrain. BMC Genomics (2011) 0.99
Creutzfeldt-Jakob disease. Adv Exp Med Biol (2012) 0.99
Solution structure of mu-conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels. J Biol Chem (2002) 0.98
Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay. Neuroreport (2008) 0.98
Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol (2005) 0.98
Brain banking for neurological disorders. Lancet Neurol (2013) 0.97
Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol (2008) 0.97
vCJD prion acquires altered virulence through trans-species infection. Biochem Biophys Res Commun (2006) 0.96
Inter-laboratory assessment of PrPSc typing in creutzfeldt-jakob disease: a Western blot study within the NeuroPrion Consortium. Brain Pathol (2008) 0.95
Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions. Biochem Biophys Res Commun (2002) 0.95
Comparison of the level, distribution and form of disease-associated prion protein in variant and sporadic Creutzfeldt-Jakob diseased brain using conformation-dependent immunoassay and Western blot. J Gen Virol (2010) 0.95
Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study. J Pathol (2010) 0.94
Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis. Cancer Res (2011) 0.94
Alterations in dihydropyridine receptors in dystrophin-deficient cardiac muscle. Am J Physiol Heart Circ Physiol (2006) 0.93
The regional genetic and newborn screening service collaboratives: the first two years. Ment Retard Dev Disabil Res Rev (2006) 0.93
Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog (2008) 0.93
Variant CJD. 18 years of research and surveillance. Prion (2014) 0.93